Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer.
Sign Up to like & getrecommendations! Published in 2019 at "JAMA surgery"
DOI: 10.1001/jamasurg.2019.1629
Abstract: Importance Earlier studies on the cost of muscle-invasive bladder cancer treatments lack granularity and are limited to 180 days. Objective To compare the 1-year costs associated with trimodal therapy vs radical cystectomy, accounting for survival… read more here.
Keywords: therapy; bladder cancer; trimodal therapy; radical cystectomy ... See more keywords
Induction chemoradiotherapy for esophageal cancer: Comparing CROSS regimen with cisplatin/5-FU.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.4070
Abstract: 4070Background: While trimodal therapy with neoadjuvant carboplatin/paclitaxel (CP) has demonstrated superiority over surgery alone for treatment of locally advanced esophageal cancer (LAEC), its superiority to alternative regimens is yet unproven. Here we directly compare CP… read more here.
Keywords: esophageal cancer; esophageal; chemoradiotherapy esophageal; induction chemoradiotherapy ... See more keywords
Population-based outcomes comparing radical cystectomy with trimodal therapy for patients diagnosed with localized muscle-invasive bladder cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e16029
Abstract: e16029 Background: Radical cystectomy is the guideline-recommended treatment for muscle-invasive bladder cancer; however, use of trimodal therapy, which utilizes a combination of surgery, radiation, and chemotherapy, has increased in recent years with conflicting survival outcomes.… read more here.
Keywords: bladder cancer; radical cystectomy; cancer; trimodal therapy ... See more keywords
Comparing radical cystectomy with trimodal therapy for patients diagnosed with bladder cancer: Critical assessment of statistical methodology and interpretation of observational data.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.7_suppl.373
Abstract: 373 Background: Treatment guidelines for muscle-invasive bladder cancer recommend radical cystectomy. However, use of trimodal therapy has increased in recent years with conflicting survival outcomes. The aim of this study was to compare radical cystectomy… read more here.
Keywords: radical cystectomy; trimodal therapy; methodology; cancer ... See more keywords
Distribution of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma After Trimodal Therapy
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-020-09106-0
Abstract: Background Although metastatic tumors in lymph nodes (LN) are potentially affected by neoadjuvant chemoradiotherapy (NCRT), the distribution of LN metastases of esophageal squamous cell carcinoma (ESCC) after trimodal therapy has never been sufficiently estimated. Patients… read more here.
Keywords: cell carcinoma; squamous cell; metastasis; esophageal squamous ... See more keywords
Molecular subtyping, tumor infiltration, and trimodal therapy for muscle-invasive bladder cancer: more questions than answers.
Sign Up to like & getrecommendations! Published in 2019 at "Translational andrology and urology"
DOI: 10.21037/tau.2019.05.12
Abstract: Trimodal therapy (TMT) is currently accepted as a suitable alternative to radical cystectomy (RC) with perioperative chemotherapy for muscle-invasive bladder cancer (MIBC). Recent publications demonstrated that survival outcomes are comparable when patients are appropriately selected… read more here.
Keywords: invasive bladder; bladder cancer; trimodal therapy; muscle invasive ... See more keywords
Trimodal Therapy in Esophageal Squamous Cell Carcinoma: Role of Adjuvant Therapy Following Neoadjuvant Chemoradiation and Surgery
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14153721
Abstract: Simple Summary In this work, we aimed to explore the effectiveness of adjuvant therapy after trimodal therapy (neoadjuvant chemoradiotherapy and esophagectomy) in patients with thoracic esophageal squamous cell carcinoma (ESCC). Overall survival (OS) and disease-free… read more here.
Keywords: chemoradiotherapy esophagectomy; neoadjuvant chemoradiotherapy; therapy; adjuvant therapy ... See more keywords
Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14235766
Abstract: Simple Summary Trimodal therapy represents an accepted treatment option for non-metastatic muscle-invasive bladder cancer, which is an alternative to radical cystectomy. Evidence regarding trimodal therapy efficacy has predominantly, or even exclusively, been applied to urothelial… read more here.
Keywords: trimodal therapy; bladder cancer; cancer; carcinoma ... See more keywords